跳转至内容
Merck
所有图片(1)

Key Documents

1.07960

Sigma-Aldrich

Entellan

rapid mounting medium for microscopy

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352401
NACRES:
NA.21

品質等級

自燃溫度

>250 °C

expl. lim.

1.2-8 % (v/v) toluene()

IVD

for in vitro diagnostic use

顏色

colorless

折射率

n20/D 1.492-1.500

轉變溫度

flash point 8 °C

密度

0.93 g/cm3

應用

diagnostic assay manufacturing
hematology
histology

儲存溫度

15-25°C

一般說明

Entellan- rapid mounting medium for microscopy, is a ready-to-use, water-free mounting medium for microscopy for the permanent mounting of specimen is an anhydrous mounting medium for microscopy used for the permanent mounting and storage of specimens, and consists of a polymer made of mixed acrylates dissolved in toluene. As it contains toluene, it should be used with water-free specimens that have been processed with xylene previous mounting. Due to its registration as IVD product and CE certification, it can be used in the manual or automated application in a diagnostic laboratory. For more details, please see instructions for use (IFU). The IFU can be downloaded from this webpage.

Refractive index (20°C) 1.492 - 1.500 at 20°C
Density (20°C / 4°C) 0.925 - 0.935 g/cm3
Viscosity (20°C) 60 - 100 mPa*s
Fluorescence < 100 ppb

分析報告

Refractive index (n 20/D): 1.492 - 1.500
Density (d 20 °C/ 4 °C): 0.925 - 0.935
Fluorescence (as quinine at 365 nm): ≤ 100 ppb
Viscosity (20 °C): 60 - 100 mPa∙s
Suitability for microscopy: passes test

法律資訊

ENTELLAN is a trademark of Merck KGaA, Darmstadt, Germany

訊號詞

Danger

危險分類

Aquatic Chronic 3 - Asp. Tox. 1 - Flam. Liq. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 2 - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

3 - Flammable liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

46.4 °F

閃點(°C)

8 °C


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Danica Sims et al.
Cancers, 12(2) (2020-02-27)
Rhabdomyosarcoma is a highly aggressive malignant cancer that arises from skeletal muscle progenitor cells and is the third most common solid tumour in children. Despite significant advances, rhabdomyosarcoma still presents a therapeutic challenge, and while targeted therapy has shown promise

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门